3 ms·

What is up with all the alt-medicine spam on HN? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346970/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346970/ "

What is up with all the alt-medicine spam on HN? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346970/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346970/ "The likely false activity of curcumin in vitro and in vivo has resulted in >120 clinical trials of curcuminoids against several diseases. No double-blinded, placebo controlled clinical trial of curcumin has been successful."

PentelicoMarble 4y ago
But this posted study is placebo controlled, right? It was also published 5 years after the link you posted
natpalmer1776 4y ago
Well, HN is the target market for a lot of these things. The idea that you can take a magic pill or supplement and suddenly be better than you were is appealing to the sorts you find on here.
eganist 4y ago
The conflict statement for the paper submitted is thick, and also buried at the end of the discussion rather than conspicuously presented up front lol > The University of California, Los Angeles, owns a U.S. patent (6,274,119) entitled “Methods for Labeling ß-Amyloid Plaques and Neurofibrillary Tangles”, which has been licensed to TauMark, LLC. Drs. Small, Satyamurthy, Huang, and Barrio are among the inventors and have financial interest in TauMark, LLC. Dr. Small also reports having served as an advisor to and/or having received lecture fees from Allergan, Argentum, Axovant, Cogniciti, Forum Pharmaceuticals, Herbalife, Janssen, Lundbeck, Lilly, Novartis, Otsuka, and Pfizer. Dr. Heber reports receiving consulting fees from Herbalife, and the McCormick Science Institute. The true tell, though: > The manufacturer of Theracurmin, Theravalues Corporation, provided the Theracurmin and placebo for the trial, funds for laboratory testing of blood curcumin levels, and funds for Dr. Small's travel to the 2017 Alzheimer's Association International Conference for presentation of the findings.
- throckmortra 4y ago
  Thank you for this. I wish this community was a little more skeptical

PentelicoMarble 4y ago

But this posted study is placebo controlled, right? It was also published 5 years after the link you posted

natpalmer1776 4y ago

Well, HN is the target market for a lot of these things. The idea that you can take a magic pill or supplement and suddenly be better than you were is appealing to the sorts you find on here.

eganist 4y ago

The conflict statement for the paper submitted is thick, and also buried at the end of the discussion rather than conspicuously presented up front lol > The University of California, Los Angeles, owns a U.S. patent (6,274,119) entitled “Methods for Labeling ß-Amyloid Plaques and Neurofibrillary Tangles”, which has been licensed to TauMark, LLC. Drs. Small, Satyamurthy, Huang, and Barrio are among the inventors and have financial interest in TauMark, LLC. Dr. Small also reports having served as an advisor to and/or having received lecture fees from Allergan, Argentum, Axovant, Cogniciti, Forum Pharmaceuticals, Herbalife, Janssen, Lundbeck, Lilly, Novartis, Otsuka, and Pfizer. Dr. Heber reports receiving consulting fees from Herbalife, and the McCormick Science Institute. The true tell, though: > The manufacturer of Theracurmin, Theravalues Corporation, provided the Theracurmin and placebo for the trial, funds for laboratory testing of blood curcumin levels, and funds for Dr. Small's travel to the 2017 Alzheimer's Association International Conference for presentation of the findings.

throckmortra 4y ago
Thank you for this. I wish this community was a little more skeptical